MCEs (1 × 103cells/well) were cultured in gelatin-coated, two-well chamber slides and fixed with 4% paraformaldehyde (PFA; Wako Ltd., Osaka, Japan). PFA-fixed cells were permeabilized with 0.3% Triton X-100 (Sigma-Aldrich, St. Louis, MO). After blocking with 10% normal donkey serum, the cells were treated with the following monoclonal primary antibodies: anti-p63 (1:100, 4A4; Santa Cruz Biotechnology, Inc., Santa Cruz, CA), anti-keratin (K)19 (1:100; NeoMarkers for Laboratory Vision Corporation, Fremont, CA), anti-involucrin (1:100; Covance, Emeryville, CA), and anti-K12 (1:100; Santa Cruz Biotechnology). Cells were then treated with Cy3-conjugated secondary antibodies (Chemicon International, Inc., Temecula, CA). Nuclei were counterstained with 4′,6′-diamino-2-phenylindole (1 μg/mL, DAPI; Dojindo Laboratories, Tokyo, Japan).